In partnership with

Anna's Daybreak News

_{Just facts, you think for yourself}

Tuesday, 5:23 AM

September 23, 2025

Good morning news friend! See how today’s unfolding moments are shaping the path to tomorrow. 📰🌟

Notice: If you’re reading this email in the Gmail app, you will not be able to see both of our health articles at the bottom. 👉 Click here to view the full newsletter online — it’s free and easy to read.

The biggest threat to your retirement isn't the stock market; it's the healthcare bill you haven't planned for. Read our latest deep dive “The Healthcare Hammer”

ABC Reinstates Jimmy Kimmel

Disney will reinstate "Jimmy Kimmel Live!" on ABC after a brief suspension due to backlash over Kimmel's comments about the assassination of Charlie Kirk.

The show was suspended on September 18, amid threats of regulatory scrutiny from FCC Chairman Brendan Carr and conservative criticism, including from Senator Ted Cruz. During the suspension, some consumers canceled Disney+ subscriptions.

While Kimmel will address the situation upon his return, it is uncertain if he will apologize. Major ABC affiliates, Sinclair and Nexstar, initially planned not to air the show. Over 400 Hollywood figures have endorsed Kimmel.

Sources: Bloomberg, Reuters, AP News, NYTimes, Archive, FinancialTimes.

Trump, Autism and Tylenol

President Trump advised pregnant women to avoid Tylenol, linking it to autism. The FDA stated no established connection exists between Tylenol and autism, despite ongoing debates.

Trump also associated Tylenol and vaccines with rising autism rates, which experts attribute to broader definitions and increased awareness rather than environmental factors.

A 2024 study involving 2.5 million Swedish siblings found no increased autism risk from maternal acetaminophen use. The American College of Obstetricians and Gynecologists maintains acetaminophen is safe during pregnancy for pain and fever.

Sources: Bloomberg, Bloomberg, Reuters, AP News, AP News, NYTimes.

Nvidia and OpenAI $100 Billion Partnership

Nvidia plans to invest up to $100 billion in OpenAI to create advanced data centers with a capacity of at least 10 gigawatts. This capacity can power over 8 million U.S. households.

Nvidia will provide essential chips for AI training, starting with a $10 billion investment as the first gigawatt comes online in late 2026. Following the announcement, Nvidia's shares rose 4.4%, increasing its market cap to about $4.5 trillion.

The investment raises antitrust concerns due to potential benefits from OpenAI's chip purchases, prompting analyst caution regarding competition in the AI sector. The partnership represents a major tech industry deal.

Sources: Bloomberg, Reuters, Openai, FinancialTimes, CNBC.

NATO on Alert

Estonia invoked NATO's Article 4 after three Russian MiG-31 jets violated its airspace for 12 minutes on September 19. This is the ninth invocation since NATO's formation, with Poland recently activating Article 4 as well.

NATO officials will hold consultations following Estonia's request, emphasizing collective security amid rising tensions. Russia denied wrongdoing and accused Estonia of fabricating claims.

The UK expressed concerns about the risk of armed conflict, with NATO reaffirming its readiness to defend its territory. Discussions under Article 4 may lead to joint decisions, while Article 5 remains the stronger collective defense measure, invoked only once post-9/11.

Sources: AP News, Reuters, Newsweek, Impakter.

The Nutrient That May Supercharge Cancer Immunotherapy

Recent research indicates that zeaxanthin, a carotenoid, enhances immune responses against cancer by boosting CD8+ T cells.

Laboratory experiments show it strengthens T-cell receptor complexes, increasing T-cell activation and cytokine production, which improves tumor-killing capacity. Mouse studies reveal that zeaxanthin in the diet slows tumor progression and enhances anti-tumor activity when combined with immune checkpoint inhibitors.

Tests with human T cells also show improved elimination of melanoma, multiple myeloma, and glioblastoma. Available as an inexpensive supplement, zeaxanthin has a strong safety profile. Further clinical trials are needed to confirm its potential in cancer therapy and explore nutritional immunology’s impact on the immune system.

Sources: SciTechDaily, Newatlas, Medicalxpress.

Key Brain Cells Behind Depression

Researchers analyzed post-mortem brain tissue from 59 individuals with depression and 41 without, finding changes in gene activity in excitatory neurons and microglia cells.

These brain cells are linked to mood regulation and inflammation management. The study indicates that gene function differs in those with depression, challenging preconceived notions about the disorder.

The senior author highlights that depression involves measurable brain changes. The team aims to explore how these cellular alterations affect brain function and whether targeting these cells might improve treatment options for the 264 million people affected by depression worldwide.

Sources: SciTechDaily.

“You must consider the storyteller more than the story: be cautious of a man's praise, and be twice as cautious of his blame, for an axe to grind has a way of making a man a powerful and enthusiastic liar.”

Did you know we also write in-depth deep dives? They are long, packed with insights, and have received rave reviews. If you’re up for a detailed, action-packed read, check them out:

• The Healthcare Hammer

• The Resilient Retirement

• Inflammation Crisis

• AI Proof Professionals

Baked with love,

Anna Eisenberg ❤️